A Phase I Safety Study of NVG-291 in Healthy Adults

Clinical trial NCT05308953 · COMPLETED

Trial details

NCT number: NCT05308953
Sponsor: NervGen Pharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Spinal Cord Injury

Start date: 2021-05-06
Primary completion: 2023-06-04
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.